Interferon-A gene therapy prevents aflatoxin and carbon tetrachloride promoted hepatic carcinogenesis in rats

International Journal of Molecular Medicine

Volumn 15, Issue 1, 2005, Pages 21-26

  Aziz, Talaat Abdel ^a   Aziz, Mohammed Abdel ^a   Fouad, Hanan Hassan ^a   Rashed, Laila Ahmed ^a   Salama, Hosny ^b   Abd Alla, S Amira ^c   Wehab, Mosaad Attia Abdel ^d   Ahmed, Tauseef ^e  

^a CAIRO UNIVERSITY   (Egypt)

^b National Research Center ^*  (United Kingdom)

^c CAIRO UNIVERSITY   (Egypt)

^d NATIONAL RESEARCH CENTRE   (Egypt)

^e NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Aflatoxin; Carbon tetrachloride; Hepatic carcinogenesis; Interferon Alpha

Indexed keywords

AFLATOXIN; ALPHA INTERFERON; CARBON TETRACHLORIDE; GLUTATHIONE S TRANSFERASE PLACENTAL ISOENZYME; GLUTATHIONE TRANSFERASE; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; ISOENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GENE EXPRESSION; IN VIVO GENE TRANSFER; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NODULE; MALIGNANT TRANSFORMATION; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE THERAPY; ANIMAL; CELL LINE; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; GENE THERAPY; GENETIC TRANSDUCTION; GENETICS; LIVER; LIVER TUMOR; MALE; METABOLISM; PATHOLOGY; PLACENTA;

AFLATOXINS; ANIMALS; CARBON TETRACHLORIDE; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; GENE THERAPY; GLUTATHIONE TRANSFERASE; INTERFERON-ALPHA; ISOENZYMES; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PLACENTA; RATS; TRANSDUCTION, GENETIC;

EID: 21644438894     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sun CA, Wang LY, Chen CJ, Lu SN, You SL, Wang LW, Wang Q, Wu DM and Santella RM: Genetic polymorphism of glutathione S-Transferase Ml and Tl associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: A nested case control study in Taiwan. Carcinogenesis 22: 1289-1294, 2001.
2. Tiemersma EW, Omer RE, Bunschoten A, Pieter VV, Kok FJ, Idris MO, Kadaru AMY, Fedail SS and Kampman E: Role of genetic polymorphism of glutathione S-Transferase Tl and microsomal epoxide hydrolase in aflatoxin-Associated hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 10:785-791, 2001.
3. Wang JS and Groopman JD: DNA damage by mycotoxins. Mutat Res 424: 167-18, 1999.
4. Eaton DL, Ramsdell HS and Neal GE: Biotransformations of anatoxins. In: The Toxicology of Aflatoxin: Human Health, Veterinary and Agricultural Significance. Eaton DL and Groopman JD (eds). Academic Press Inc., San Diego, CA, pp 45-71. 1994.
5. Guengerich FP, Johnson WW, Ueng YF, Yamazaki H and Shimada T: Involvement of cytochrome P450, glutathione Stransferase and epoxide hydrolase in the metabolism of aflatoxin Bl and relevance to risk of human liver cancer. Environ Health Perspect 104 (suppl 3): 557-562, 1996.
6. Qin G, Ning Y, Jianjia S, Shinozuka H and Prabhakar DL: Enhancement of aflatoxin B1-induced enzyme altered hepatic foci in rats by treatment with carbon tetrachloride. Exp Mol Med 30: 186-191, 1998.
7. Hiruma S, Qin GZ, Gopalan-Kriczky P, Sato K and Lotlikar PD: Effect of cell proliferation on initiation of aflatoxin Bl-induced enzyme altered hepatic foci in rats and hamsters. Carcinogenesis 17:2495-2499, 1996.
8. Shen H, Manna Z, Minuk GY and Gong Y: Different effects of rat interferon alpha, beta and gamma on rat hepatic stellate cells proliferation and activation. Cell Biol 3: 9-13, 2002.
9. Suzuki K, Aoki K, Ohnami S, Yoshida K, Kazui T, Inoue K, Kohara M and Yoshida T: Adenovirus-mediated gene transfer of interferon alpha improves dimethyl-nitroseamine-induced liver cirrhosis in rat model. Gene Ther 10: 765-773, 2003.
10. Sell S: Mouse models to study the interaction of risk factors for human liver cancer. Cancer Res 63: 7553-7562, 2003.
11. Shupe T and Sell S: Low hepatic glutathione S-Transferase and increased hepatic DNA adduction contribute to increased tumorigenicity of aflatoxin Bl in newborn and partially hepatectomized mice. Toxicol Lett 148: 1-9, 2004.
12. Cupid BC, Lightfoot TJ, Russell D, Gant SJ, Turner PC, Dingley KH, Curtis KD, Leveson SH, Turteltaub KW and Garner RC: The formation of AFB(l)-macromolecular adducts in rats and humans at dietary levels of exposure. Food Chem Toxicol 42: 559-569, 2004.
13. Park DH, Lee MS, Kim HJ, Kim HS, Lee YL, Kwon MS, Jang JJ and Lee MJ: Chronic hepatotoxicity of carbon tetrachloride in hsp-70 knock out mice. Exp Anim 53: 27-30, 2004.
14. Ogura H, Tani K, Ozawa K, Nagatz S, Asano S and Takaku F: Implantation of genetically manipulated fibroblasts into mice as antitumor alpha interferon therapy. Cancer Res 50: 5102-5106, 1990.
15. Markowitz D, Goff S and Bank A: A safe packaging line for gene transfer separating viral genes into two different Plasmids. J Virol 62: 1120-1124, 1998.
16. Ledda-Columbano GM, Coni P, Curto M, Giacomini L, Faa G, Samna DS and Columbano A: Mitogen induced liver hyperplasia does not substitute for compensatory regeneration during promotion of chemical carcinogenesis. Carcinogenesis 13: 379-383, 1992.
17. Abdel-Ghaffar Y, Abdel Aziz TM, El-Meligy D and Fouad HH: The role of endotoxin in liver injury. M.D. Thesis. Medical Biochemistry. Faculty of Medicine, Cairo University, pp 155-156, 1994.
18. Pestka S, Langer JA, Zoon KC and Samuel CE: Interferons and their actions. Annu Rev Biochem 56: 727-777, 1987.
19. Mallat A, Preaux AM, Blazejewski S, Rosenbaum J, Dhumeaux D and Mavier P: Interferon alpha and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 21: 1003-1010, 1995.
20. Manabe N, Chevallier M, Choosegros P, Causse X, Guerret S, Trepo C and Grimaud JA: Interferon-Alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation. Hepatology 18: 1344-1349, 1993.
21. Pestka S: The human interferon alpha species and receptors. Biopolymers 55: 254-287, 2000.
22. Horton HM, Anderson D, Hernandez P, Kerry MB, Norman JA and Parker SE: A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon a. Proc Natl Acad Sei 96: 1553-1558, 1999.
23. Pfeffer LM, Dinarello CA, Heberman RB, Williams BR, Bordon EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP and Pestka S: Biological properties of recombinant alpha interferons: 40Ih anniversary of the discovery of interferons. Cancer Res 58: 2489-2499, 1998.
24. Quan S, Seiter K, Feldman E, Yang L, Argani I, Farley TJ, Abraham NG and Ahmed T: Human CD34+ hematopoitic cells transduced by retro virus-mediated interferon alpha gene maintains regeneration capacity and engraftment in NOD/DCID mice. Exp Hematol 27: 1511-1518, 1999.